Status:
COMPLETED
Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Canon Medical Systems, USA
Siemens Medical Solutions
Conditions:
Liver Fibrosis
Liver Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic liver disease is a major problem in the general population and there is an unmet need to diagnose(and screen) for liver disease with using noninvasive, cost-effective and sensitive techniques....
Detailed Description
Liver disease and cirrhosis are important causes of morbidity and mortality in the United States and are a major public health problem with 40,000 deaths and more than 1.4 billion dollars spent on med...
Eligibility Criteria
Inclusion
- Adult Patients
- Men or Woman
- Suspected diffuse liver disease and have had a liver biopsy within the last 6 months or are scheduled for a liver biopsy in the next 3 months.
- Consent to participate in the study
Exclusion
- Pregnancy
- Acute illness/ cognitive impairment resulting in inability to cooperate with ultrasound
- Patients that do not consent to ultrasound examination
Key Trial Info
Start Date :
June 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03342560
Start Date
June 29 2017
End Date
August 30 2018
Last Update
October 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114